J W Smith|S R Jones - JoVE Visualize

Showing results (691-700 of 780) with videos related to

Pageof 78

Sort By:

Blood|March 27, 2001

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinomaJ E Janik, L L Miller, E L Korn, et al.

Transfusion|October 19, 2001

Multicenter evaluation of PCR methods for detecting CMV DNA in blood donorsJ D Roback, C D Hillyer, W L Drew, et al.

The Journal of Infectious Diseases|December 12, 1997

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study GroupE L Murphy, S A Glynn, J Fridey, et al.

Blood|May 1, 1996

A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapyI Tepler, L Elias, J W Smith, et al.

Journal of Cancer Research and Clinical Oncology|June 8, 1999

Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trialK A Margolin, P Y Liu, J M Unger, et al.

Transfusion|July 1, 2005

The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusionS H Kleinman, S A Glynn, M J Higgins, et al.

Journal of Neural Engineering|November 5, 2020

NeuroDAC: an open-source arbitrary biosignal waveform generatorM P Powell, J Anso, R Gilron, et al.

Journal of Clinical Microbiology|March 21, 1998

Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genesC H Lee, J Helweg-Larsen, X Tang, et al.

Developments in Biologicals|December 18, 2004

Manipulating the host response to autologous tumour vaccinesJ Ma, C H Poehlein, S M Jensen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996

Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancerB L Gause, M Sznol, W C Kopp, et al.

Pageof 78

Showing results (691-700 of 780) with videos related to

Sort By:

Pageof 78

Blood|March 27, 2001

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinomaJ E Janik, L L Miller, E L Korn, et al.

Transfusion|October 19, 2001

Multicenter evaluation of PCR methods for detecting CMV DNA in blood donorsJ D Roback, C D Hillyer, W L Drew, et al.

The Journal of Infectious Diseases|December 12, 1997

Increased prevalence of infectious diseases and other adverse outcomes in human T lymphotropic virus types I- and II-infected blood donors. Retrovirus Epidemiology Donor Study (REDS) Study GroupE L Murphy, S A Glynn, J Fridey, et al.

Blood|May 1, 1996

A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapyI Tepler, L Elias, J W Smith, et al.

Journal of Cancer Research and Clinical Oncology|June 8, 1999

Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trialK A Margolin, P Y Liu, J M Unger, et al.

Transfusion|July 1, 2005

The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusionS H Kleinman, S A Glynn, M J Higgins, et al.

Journal of Neural Engineering|November 5, 2020

NeuroDAC: an open-source arbitrary biosignal waveform generatorM P Powell, J Anso, R Gilron, et al.

Journal of Clinical Microbiology|March 21, 1998

Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genesC H Lee, J Helweg-Larsen, X Tang, et al.

Developments in Biologicals|December 18, 2004

Manipulating the host response to autologous tumour vaccinesJ Ma, C H Poehlein, S M Jensen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996

Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancerB L Gause, M Sznol, W C Kopp, et al.

Pageof 78